Back to Screener

Healthcare

Niagen Bioscience Inc(NAGE)

Live Price

Offline

$3.32

-3.77% today

1Y Change

-74.67%

Window

Jun 26, 2025 โ†’ Jun 18, 2026

Market Cap
$390.00M
Revenue Growth
+29.9%
EPS Growth
+120.0%
Dividend Yield
0.0%

Coverage: 246 bars ยท Jun 26, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Niagen Bioscience Inc (NAGE) is a Healthcare stock with a market cap of $390.00M and listed on NASDAQ. The stock last traded around $3.32 and down 74.7% across the available one-year price window (Jun 26, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +29.9%, EPS growth of +120.0%, a dividend yield of 0.0%. What stands out right now is revenue +29.9%, EPS +120.0%, free cash flow +10.0% with operating margin 11.0% and ROIC 15.6%. Valuation is more restrained than many high-expectation growth names at P/E 22.0 and price/sales 3.0. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NAGE price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

NAGE vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

NAGE

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

NAGE Max Drawdown

-76.61%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for NAGE and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 6, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 6, 26
โ€”
Est 0.06
โ€”
โ€”
Est 30362.5B
โ€”
May 6
โ€”
Mar 4, 26
โœ“
0.03
Est 0.02
+50.0%
33839.0B
Est 31701.4B
+6.7%
Mar 4
โ€”
Nov 4, 25
โœ“
0.05
Est 0.01
+233.3%
33986.0B
Est 31102.0B
+9.3%
Nov 4
โ€”
Aug 6, 25
โœ“
0.04
Est 0.02
+100.0%
31117.0B
Est 30762.3B
+1.1%
Aug 6
โ€”
May 7, 25
โœ“
0.04
Est 0.02
+100.0%
30481.0B
Est 27075.0B
+12.6%
May 7
โ€”
Mar 4, 25
โœ“
0.03
Est 0.02
+50.0%
29125.0B
Est 26775.0B
+8.8%
Mar 4
โ€”
Oct 31, 24
โœ“
0.02
Est 0.01
+100.0%
25580.0B
Est 24032.5B
+6.4%
Oct 31
โ€”
Jun 30, 24
โœ“
-0.00
Est -0.02
+99.0%
22739.0B
Est 23325.0B
-2.5%
Jun 30
โ€”
Mar 31, 24
โœ“
-0.01
Est -0.02
+67.3%
22153.0B
Est 23475.0B
-5.6%
Mar 31
โ€”
Dec 31, 23
โœ“
0.00
Est -0.02
+106.8%
21196.0B
Est 20812.5B
+1.8%
Dec 31
โ€”
Sep 30, 23
โœ“
-0.01
Est -0.03
+57.4%
19495.0B
Est 20296.0B
-4.0%
Sep 30
โ€”
Jun 30, 23
โœ“
-0.03
Est -0.04
+26.9%
20323.0B
Est 19418.0B
+4.7%
Jun 30
โ€”
Mar 31, 23
-0.03
Est โ€”
โ€”
22556.0B
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 22
โœ“
-0.02
Est -0.05
+58.8%
20996.0B
Est 19405.3B
+8.2%
Dec 31
โ€”
Sep 30, 22
-0.01
Est โ€”
โ€”
17063.0B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 22
-0.09
Est โ€”
โ€”
16732.0B
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 22
-0.11
Est โ€”
โ€”
17259.0B
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 21
-0.08
Est โ€”
โ€”
17759.0B
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 21
-0.13
Est โ€”
โ€”
17308.0B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 21
-0.08
Est โ€”
โ€”
17699.0B
Est โ€”
โ€”
Jun 30
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener